Traders sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Friday. $119.18 million flowed into the stock on the tick-up and $173.22 million flowed out of the stock on the tick-down, for a money net flow of $54.04 million out of the stock. Of all stocks tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $0.47 for the day and closed at $119.04

A number of research analysts recently commented on the company. BTIG Research cut Johnson & Johnson from a “buy” rating to a “neutral” rating in a report on Thursday, May 12th. Morgan Stanley reiterated a “hold” rating on shares of Johnson & Johnson in a report on Thursday, May 19th. Wells Fargo & Co. reiterated a “buy” rating on shares of Johnson & Johnson in a report on Monday, July 11th. BMO Capital Markets reiterated an “outperform” rating and issued a $132.00 price objective on shares of Johnson & Johnson in a report on Wednesday, July 20th. Finally, Zacks Investment Research upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 price objective on the stock in a report on Friday, August 5th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and twelve have given a buy rating to the company’s stock. Johnson & Johnson currently has a consensus rating of “Hold” and a consensus price target of $119.53.

The firm has a 50 day moving average of $122.92 and a 200 day moving average of $114.31. The firm has a market capitalization of $325.68 billion and a price-to-earnings ratio of 22.18.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, July 19th. The company reported $1.74 EPS for the quarter, beating the Zacks’ consensus estimate of $1.68 by $0.06. The business earned $18.50 billion during the quarter, compared to analysts’ expectations of $17.98 billion. Analysts expect that Johnson & Johnson will post $6.69 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 19th. Stockholders of record on Friday, August 5th were paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.97%.

In other news, VP Dominic J. Caruso sold 41,146 shares of the firm’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $125.01, for a total value of $5,143,661.46. Following the transaction, the vice president now owns 157,819 shares of the company’s stock, valued at approximately $19,728,953.19. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Ronald A. Kapusta sold 3,000 shares of the firm’s stock in a transaction on Tuesday, June 7th. The shares were sold at an average price of $115.79, for a total transaction of $347,370.00. Following the completion of the transaction, the chief accounting officer now directly owns 28,725 shares in the company, valued at approximately $3,326,067.75. The disclosure for this sale can be found here.

Other large investors have recently added to or reduced their stakes in the company. Private Capital Management Inc. purchased a new stake in Johnson & Johnson during the fourth quarter valued at about $1,428,000. Holderness Investments Co. increased its stake in Johnson & Johnson by 2.1% in the fourth quarter. Holderness Investments Co. now owns 14,942 shares of the company’s stock valued at $1,535,000 after buying an additional 302 shares during the period. Security National Bank of SO Dak increased its stake in Johnson & Johnson by 4.7% in the fourth quarter. Security National Bank of SO Dak now owns 16,302 shares of the company’s stock valued at $1,674,000 after buying an additional 731 shares during the period. West Chester Capital Advisors Inc. increased its stake in Johnson & Johnson by 12.6% in the fourth quarter. West Chester Capital Advisors Inc. now owns 17,746 shares of the company’s stock valued at $1,804,000 after buying an additional 1,984 shares during the period. Finally, Wafra Investment Advisory Group Inc. NY increased its stake in Johnson & Johnson by 10.0% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 22,608 shares of the company’s stock valued at $2,322,000 after buying an additional 2,058 shares during the period.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.